News

Cinclus Pharma Holding AB: Cinclus Pharma secures EMA and FDA pediatric study waivers for linaprazan glurate in H. pylori infection
Cinclus Pharma AB (publ), a clinical-stage pharmaceutical company developing next generation treatments for acid-related diseases, today announced that the European Medicines Agency (EMA) and the US F ...
EQS-News: LS telcom AG: LS telcom veröffentlicht Halbjahreszahlen 2024/2025
EQS-News: LS telcom AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht LS telcom veröffentlicht Halbjahreszahlen 2024/2025 16.06.2025 / 11:06 CET/CEST Für den Inhalt ...
Integrum AB: Integrum appoints Louise Wåhlin as new Chief Financial Officer
Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on her ...
Announcement regarding the governance of Renault Group: CEO Luca de Meo steps down
Announcement regarding the governance of Renault Group Boulogne-Billancourt, June 15,2025 - After 5 years at the head of Renault Group, Luca de Meo has announced his decision ...
Akeso, Inc.: Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16 ...
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA (ustekinumab-stba), expanding dosing options for pediatric patients
Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or ...
Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
Freedom Holding Corp. (NASDAQ: FRHC), the diversified financial group with operations spanning 22 countries, today ...